-
1
-
-
84875230309
-
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
-
Stern M, Passweg JR, Meyer-Monard S, Esser R, Tonn T, Soerensen J, et al. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant (2013) 48:433-8. doi: 10.1038/bmt.2012.162.
-
(2013)
Bone Marrow Transplant
, vol.48
, pp. 433-438
-
-
Stern, M.1
Passweg, J.R.2
Meyer-Monard, S.3
Esser, R.4
Tonn, T.5
Soerensen, J.6
-
2
-
-
53549114206
-
NK cells and cancer immunosurveillance
-
Waldhauer I, Steinle A. NK cells and cancer immunosurveillance. Oncogene (2008) 27:5932-43. doi:10.1038/onc.2008.267.
-
(2008)
Oncogene
, vol.27
, pp. 5932-5943
-
-
Waldhauer, I.1
Steinle, A.2
-
3
-
-
10644291011
-
The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor
-
Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol (2005) 42:485-8. doi:10.1016/j.molimm.2004.07.031.
-
(2005)
Mol Immunol
, vol.42
, pp. 485-488
-
-
Borrego, F.1
Masilamani, M.2
Kabat, J.3
Sanni, T.B.4
Coligan, J.E.5
-
4
-
-
84883244752
-
Natural killer cell biology: an update and future directions
-
Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions. J Allergy Clin Immunol (2013) 132:536-44. doi:10.1016/j.jaci.2013.07.006.
-
(2013)
J Allergy Clin Immunol
, vol.132
, pp. 536-544
-
-
Campbell, K.S.1
Hasegawa, J.2
-
5
-
-
80053208226
-
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
-
Curti A, Ruggeri L, D'Addio A, Bontadini A, Dan E, Motta MR, et al. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. Blood (2011) 118:3273-9. doi:10.1182/blood-2011-01-329508.
-
(2011)
Blood
, vol.118
, pp. 3273-3279
-
-
Curti, A.1
Ruggeri, L.2
D'Addio, A.3
Bontadini, A.4
Dan, E.5
Motta, M.R.6
-
6
-
-
42449123606
-
Natural killer cell-directed therapies: moving from unexpected results to successful strategies
-
Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol (2008) 9:486-94. doi:10.1038/ni1580.
-
(2008)
Nat Immunol
, vol.9
, pp. 486-494
-
-
Terme, M.1
Ullrich, E.2
Delahaye, N.F.3
Chaput, N.4
Zitvogel, L.5
-
7
-
-
67650433317
-
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
-
Sutlu T, Alici E. Natural killer cell-based immunotherapy in cancer: current insights and future prospects. J Intern Med (2009) 266:154-81. doi:10.1111/j.1365-2796.2009.02121.x.
-
(2009)
J Intern Med
, vol.266
, pp. 154-181
-
-
Sutlu, T.1
Alici, E.2
-
8
-
-
0033168770
-
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
-
Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood (1999) 94:333-9.
-
(1999)
Blood
, vol.94
, pp. 333-339
-
-
Ruggeri, L.1
Capanni, M.2
Casucci, M.3
Volpi, I.4
Tosti, A.5
Perruccio, K.6
-
9
-
-
0037086131
-
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
-
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295:2097-100. doi:10.1126/science.1068440.
-
(2002)
Science
, vol.295
, pp. 2097-2100
-
-
Ruggeri, L.1
Capanni, M.2
Urbani, E.3
Perruccio, K.4
Shlomchik, W.D.5
Tosti, A.6
-
10
-
-
34347396957
-
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value
-
Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood (2007) 110:433-40. doi:10.1182/blood-2006-07-038687.
-
(2007)
Blood
, vol.110
, pp. 433-440
-
-
Ruggeri, L.1
Mancusi, A.2
Capanni, M.3
Urbani, E.4
Carotti, A.5
Aloisi, T.6
-
11
-
-
63849104548
-
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
-
Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood (2009) 113:3119-29. doi:10.1182/blood-2008-06-164103.
-
(2009)
Blood
, vol.113
, pp. 3119-3129
-
-
Pende, D.1
Marcenaro, S.2
Falco, M.3
Martini, S.4
Bernardo, M.E.5
Montagna, D.6
-
12
-
-
8844228916
-
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
-
Passweg JR, Tichelli A, Meyer-Monard S, Heim D, Stern M, Kühne T, et al. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation. Leukemia (2004) 18:1835-8. doi:10.1038/sj.leu.2403524.
-
(2004)
Leukemia
, vol.18
, pp. 1835-1838
-
-
Passweg, J.R.1
Tichelli, A.2
Meyer-Monard, S.3
Heim, D.4
Stern, M.5
Kühne, T.6
-
13
-
-
10744230735
-
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
-
Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood (2003) 102:814-9. doi:10.1182/blood-2003-01-0091.
-
(2003)
Blood
, vol.102
, pp. 814-819
-
-
Giebel, S.1
Locatelli, F.2
Lamparelli, T.3
Velardi, A.4
Davies, S.5
Frumento, G.6
-
14
-
-
0037111776
-
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor
-
Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood (2002) 100:3825-7. doi:10.1182/blood-2002-04-1197.
-
(2002)
Blood
, vol.100
, pp. 3825-3827
-
-
Davies, S.M.1
Ruggieri, L.2
DeFor, T.3
Wagner, J.E.4
Weisdorf, D.J.5
Miller, J.S.6
-
15
-
-
1642377663
-
Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors
-
Bornhäuser M, Schwerdtfeger R, Martin H, Frank KH, Theuser C, Ehninger G. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood (2004) 103:2860-1. doi:10.1182/blood-2003-11-3893.
-
(2004)
Blood
, vol.103
, pp. 2860-2861
-
-
Bornhäuser, M.1
Schwerdtfeger, R.2
Martin, H.3
Frank, K.H.4
Theuser, C.5
Ehninger, G.6
-
16
-
-
33746031836
-
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
-
Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant (2006) 12:828-36. doi:10.1016/j.bbmt.2006.04.008.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 828-836
-
-
Hsu, K.C.1
Gooley, T.2
Malkki, M.3
Pinto-Agnello, C.4
Dupont, B.5
Bignon, J.D.6
-
17
-
-
10644264504
-
KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation
-
Malmberg KJ, Schaffer M, Ringdén O, Remberger M, Ljunggren HG. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol (2005) 42:531-4. doi:10.1016/j.molimm.2004.07.037.
-
(2005)
Mol Immunol
, vol.42
, pp. 531-534
-
-
Malmberg, K.J.1
Schaffer, M.2
Ringdén, O.3
Remberger, M.4
Ljunggren, H.G.5
-
18
-
-
77957734984
-
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
-
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood (2010) 116:2411-9. doi:10.1182/blood-2010-05-283051.
-
(2010)
Blood
, vol.116
, pp. 2411-2419
-
-
Cooley, S.1
Weisdorf, D.J.2
Guethlein, L.A.3
Klein, J.P.4
Wang, T.5
Le, C.T.6
-
19
-
-
84929377752
-
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality
-
Mancusi A, Ruggeri L, Urbani E, Pierini A, Massei MS, Carotti A, et al. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. Blood (2015) 125:3173-82. doi:10.1182/blood-2014-09-599993.
-
(2015)
Blood
, vol.125
, pp. 3173-3182
-
-
Mancusi, A.1
Ruggeri, L.2
Urbani, E.3
Pierini, A.4
Massei, M.S.5
Carotti, A.6
-
20
-
-
1542348559
-
Monitoring of a new approach of immunotherapy with allogeneic In-labelled NK cells in patients with renal cell carcinoma
-
Meller B, Frohn C, Brand JM, Lauer I, Schelper LF, von Hof K. Monitoring of a new approach of immunotherapy with allogeneic In-labelled NK cells in patients with renal cell carcinoma. Eur J Nucl Med Mol Imaging (2004) 31:403-7. doi:10.1007/s00259-003-1398-4.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, pp. 403-407
-
-
Meller, B.1
Frohn, C.2
Brand, J.M.3
Lauer, I.4
Schelper, L.F.5
von Hof, K.6
-
21
-
-
20144388509
-
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
-
Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood (2005) 105:3051-7. doi:10.1182/blood-2004-07-2974.
-
(2005)
Blood
, vol.105
, pp. 3051-3057
-
-
Miller, J.S.1
Soignier, Y.2
Panoskaltsis-Mortari, A.3
McNearney, S.A.4
Yun, G.H.5
Fautsch, S.K.6
-
22
-
-
77949898005
-
NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia
-
Rubnitz JE, Inaba H, Ribeiro RC, Pounds S, Rooney B, Bell T, et al. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol (2010) 28:955-9. doi:10.1200/JCO.2009.24.4590.
-
(2010)
J Clin Oncol
, vol.28
, pp. 955-959
-
-
Rubnitz, J.E.1
Inaba, H.2
Ribeiro, R.C.3
Pounds, S.4
Rooney, B.5
Bell, T.6
-
23
-
-
84902682889
-
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
-
Bachanova V, Cooley S, Defor TE, Verneris MR, Zhang B, McKenna DH, et al. Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood (2014) 123:3855-63. doi:10.1182/blood-2013-10-532531.
-
(2014)
Blood
, vol.123
, pp. 3855-3863
-
-
Bachanova, V.1
Cooley, S.2
Defor, T.E.3
Verneris, M.R.4
Zhang, B.5
McKenna, D.H.6
-
24
-
-
84870736330
-
Cytokine activation induces human memory-like NK cells
-
Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, et al. Cytokine activation induces human memory-like NK cells. Blood (2012) 120:4751-60. doi:10.1182/blood-2012-04-419283.
-
(2012)
Blood
, vol.120
, pp. 4751-4760
-
-
Romee, R.1
Schneider, S.E.2
Leong, J.W.3
Chase, J.M.4
Keppel, C.R.5
Sullivan, R.P.6
-
25
-
-
84872225254
-
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
-
Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med (2012) 209:2351-65. doi:10.1084/jem.20120944.
-
(2012)
J Exp Med
, vol.209
, pp. 2351-2365
-
-
Ni, J.1
Miller, M.2
Stojanovic, A.3
Garbi, N.4
Cerwenka, A.5
-
26
-
-
84908636831
-
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
-
Ardolino M, Azimi CS, Iannello A, Trevino TN, Horan L, Zhang L, et al. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest (2014) 124:4781-94. doi:10.1172/JCI74337.
-
(2014)
J Clin Invest
, vol.124
, pp. 4781-4794
-
-
Ardolino, M.1
Azimi, C.S.2
Iannello, A.3
Trevino, T.N.4
Horan, L.5
Zhang, L.6
-
27
-
-
68049118980
-
Loss of mismatched HLA in leukemia after stem-cell transplantation
-
Vago L, Perna SK, Zanussi M, Mazzi B, Barlassina C, Stanghellini MT, et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med (2009) 361:478-88. doi:10.1056/NEJMoa0811036.
-
(2009)
N Engl J Med
, vol.361
, pp. 478-488
-
-
Vago, L.1
Perna, S.K.2
Zanussi, M.3
Mazzi, B.4
Barlassina, C.5
Stanghellini, M.T.6
|